Premier Asset Management LLC Cerus Corp Transaction History

Premier Asset Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$5.97 - $7.93 $387,787 - $515,101	-64,956 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.79 - $6.68 $887,381 - $1.24 Million	-185,257 Reduced 74.04%	64,956 $395,000
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $268,735 - $318,966	-50,231 Reduced 16.72%	250,213 $1.48 Million
Q1 2021 May 12, 2021	BUY	$5.68 - $7.87 $909,458 - $1.26 Million	160,116 Added 114.1%	300,444 $1.81 Million
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $97,891 - $159,609	18,646 Added 15.32%	140,328 $971,000
Q3 2020 Nov 16, 2020	BUY	$5.78 - $7.47 $380,861 - $492,220	65,893 Added 118.11%	121,682 $762,000
Q2 2020 Jul 31, 2020	SELL	$4.5 - $7.02 $278,244 - $434,060	-61,832 Reduced 52.57%	55,789 $368,000
Q1 2020 May 07, 2020	BUY	$2.87 - $5.49 $337,572 - $645,739	117,621 New	117,621 $547,000
Q3 2019 Nov 01, 2019	SELL	$4.86 - $6.05 $610,566 - $760,067	-125,631 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$4.51 - $6.6 $566,595 - $829,164	125,631 New	125,631 $706,000
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $260,125 - $345,322	-50,412 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$4.89 - $7.16 $246,514 - $360,949	50,412 New	50,412 $256,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $249,898 - $349,087	-48,150 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.56 - $5.74 $106,504 - $171,723	-29,917 Reduced 38.32%	48,150 $264,000
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $136,399 - $195,209	-49,420 Reduced 38.76%	78,067 $264,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $283,021 - $348,039	127,487	127,487 $348,000

155

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $280M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.